IL1B and depressive symptom measurement: The pattern of results for IL1β is consistent with previous work that identified the high expression -511C allele as a risk for poor response to pharmacotherapies for depression, and for early onset of depression and higher depressive symptom severity (Dixon et al., 2007; Hwang et al., 2009; Tadic et al., 2008; Yu et al., 2003a).